Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’s disease and other dementias

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biomarkers

• Publication date

  2011-02-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/1354750X.2010.536995PMID 21323605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• S3‐03‐05: Proteomics‐derived cerebrospinal fluid markers of autopsy‐confirmed Alzheimer's disease

  2010influential reference
• Pigment epithelium-derived factor up-regulation induced by memantine, an N-methyl-D-aspartate receptor antagonist, is involved in increased proliferation of hippocampal progenitor cells.

  2010cited by this paper
• Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease

  2009cited by this paper
• Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

  2008cited by this paper
• Bootstrap Methods: Another Look at the Jackknife

  2008cited by this paper
• Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

  2008cited by this paper
• Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice.

  2008cited by this paper
• Inflammatory markers and the risk of Alzheimer disease

  2007cited by this paper
• A note on iterative marginal optimization: a simple algorithm for maximum rank correlation estimation

  2007cited by this paper
• Role of complement in neurodegeneration and neuroinflammation.

  2007cited by this paper
• Differential post‐translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid

  2006cited by this paper
• Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease

  2006cited by this paper
• The Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Rate of Decline in Alzheimer's disease

  2006cited by this paper
• Enzyme-Linked Immunosorbent Assay

  2006cited by this paper
• Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies

  2006cited by this paper
• Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

  2006cited by this paper
• Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease.

  2006cited by this paper
• Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

  2006influential reference
• Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects

  2006influential reference
• Amyloid-β peptide binds with heme to form a peroxidase: Relationship to the cytopathologies of Alzheimer’s disease

  2006cited by this paper
• Variable phosphorylation states of pigment-epithelium-derived factor differentially regulate its function.

  2006cited by this paper
• Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease

  2005cited by this paper
• IL-8 enhancement of amyloid-beta (Aβ1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia

  2005cited by this paper
• Phosphorylated tau predicts rate of cognitive decline in MCI subjects: A comparative CSF study

  2005influential reference
• Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.

  2005cited by this paper
• Localization of epitopes in the toxins of Tityus serrulatus scorpions and neutralizing potential of therapeutic antivenoms.

  2005cited by this paper
• Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor.

  2005cited by this paper
• Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• Haptoglobin polymorphisms and iron homeostasis in health and in disease.

  2004cited by this paper
• Antioxidant role of human haptoglobin

  2004cited by this paper
• Neuropathology of Alzheimer’s Disease

  2004cited by this paper
• Hemoglobin promotes Abeta oligomer formation and localizes in neurons and amyloid deposits.

  2004cited by this paper
• Is pigment epithelium-derived factor level in cerebrospinal fluid a promising biomarker for early diagnosis of Alzheimer's disease?

  2004cited by this paper
• CSF markers for incipient Alzheimer's disease.

  2003influential reference
• Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

  2003cited by this paper
• Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease.

  2003cited by this paper
• Monoclonal Antibody 667 Recognizes the Variable Region A Motif of the Ecotropic Retrovirus CasBrE Envelope Glycoprotein and Inhibits Env Binding to the Viral Receptor

  2003influential reference
• Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization.

  2003cited by this paper
• PEDF: a multifaceted neurotrophic factor

  2003cited by this paper
• Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

  2002cited by this paper
• A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E ε4 allele

  2002cited by this paper
• Application of the Spot method to the identification of peptides and amino acids from the antibody paratope that contribute to antigen binding.

  2002cited by this paper
• Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.

  2001cited by this paper
• Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients.

  2001influential reference
• TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

  2001cited by this paper
• Haptoglobin gene expression in human glioblastoma cell lines.

  2001cited by this paper
• Pigment epithelium‐derived factor protects cultured retinal neurons against hydrogen peroxide‐induced cell death

  1999cited by this paper
• Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.

  1999cited by this paper
• Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration.

  1999cited by this paper
• Fibroblast growth factor (FGF)-9 immunoreactivity in senile plaques.

  1998cited by this paper
• Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

  1995cited by this paper
• The neuropathology of Alzheimer's disease.

  1995cited by this paper
• Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease

  1995cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995influential reference
• Altered blood‐brain‐barrier function in Alzheimer's disease?

  1994cited by this paper
• Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

  1993cited by this paper
• Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia.

  1992cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper
• Vascular dementia is underdiagnosed.

  1988cited by this paper
• High-efficiency transformation of mammalian cells by plasmid DNA.

  1987cited by this paper
• A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

  1983cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• Haemoglobin binding with haptoglobin. Localization of the haptoglobin-binding site on the alpha-chain of human haemoglobin.

  1981cited by this paper
• Fusion between immunoglobulin‐secreting and nonsecreting myeloma cell lines

  1976cited by this paper
• Journal of Neuroinflammation Interleukin-1 Mediates Alzheimer and Lewy Body Pathologies

  year unknowncited by this paper

• Quantitative proteomics of cerebrospinal fluid using tandem mass tags in dogs with recurrent epileptic seizures.

  2020cites this paper
• Cerebrospinal fluid CD4+ T lymphocyte-derived miRNA-let-7b can enhances the diagnostic performance of Alzheimer's disease biomarkers.

  2018cites this paper
• Pigment Epithelium-Derived Factor Plays a Role in Alzheimer’s Disease by Negatively Regulating Aβ42

  2018cites this paper
• Clear differences in cerebrospinal fluid proteome between women with chronic widespread pain and healthy women – a multivariate explorative cross-sectional study

  2017cites this paper
• Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.

  2017cites this paper
• Alzheimer's disease: Elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin

  2017cites this paper
• Proteomic analysis and comparison of intra- and extracranial cerebral atherosclerosis responses to hyperlipidemia in rabbits

  2017cites this paper
• Identification of proteins that are differentially expressed in brains with Alzheimer's disease using iTRAQ labeling and tandem mass spectrometry.

  2016cites this paper
• Haptoglobin genotype modulates the relationships of glycaemic control with cognitive function in elderly individuals with type 2 diabetes

  2015cites this paper
• Cerebrospinal fluid biomarkers of Alzheimer’s disease

  2014cites this paper
• Reverse engineering of Alzheimer's disease based on biomarker pathways analysis.

  2014influential citation
• N-truncated Aβ peptides in complex fluids unraveled by new specific immunoassays.

  2013cites this paper
• Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.

  2013cites this paper
• Cerebrospinal fluid biomarkers for neurodegenerative disorders

  2013cites this paper
• Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians

  2013cites this paper
• Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease

  2013cites this paper
• Cerebrospinal Ab11-x and 17-x levels as indicators of mild cognitive impairment and patients’ stratification in Alzheimer’s disease

  2013cites this paper
• Translational proteomics in Alzheimer's disease and related disorders.

  2013cites this paper
• Fluid biomarkers for diagnosing dementia : rationale and recommendations for Canadian Physicians

  2012cites this paper
• Use of proteomic methods in the analysis of human body fluids in Alzheimer research

  2012cites this paper